Pharmaceutical industry changes and market insights: Survey of leaders in the pharma value chain

There are many conversations taking place in both public and private forums around the current state of pharmaceuticals, drug prices and public policy changes.

Parthenon-EY and YourEncore conducted a survey to ask leaders in the industry value chain what they thought of the regulatory environment and how changes may impact the industry.

What we heard was both interesting and affirming of many of the sentiments being reported by the general press: patient safety and efficacy is a priority and there is a need for simplification of rules and guidelines, wholesale change around the economic models to usher in greater transparency, and thoughtful restructuring of business and economic models.

* The opinions and viewpoints highlighted in this article are those of the survey respondents and not Ernst & Young LLP.

View the full report here.